Cargando…

Conestat alfa for the treatment of angioedema attacks

Recently, multiple C1 inhibitor (C1-INH) replacement products have been approved for the treatment of hereditary angioedema (HAE). This review summarizes HAE and its current treatment modalities and focuses on findings from bench to bedside trials of a new C1-INH replacement, conestat alfa. Conestat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Benjamin, Bernstein, Jonathan A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132097/ https://www.ncbi.nlm.nih.gov/pubmed/21753889 http://dx.doi.org/10.2147/TCRM.S15544

Ejemplares similares

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema
por: Kawalec, Paweł, et al.
Publicado: (2013)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
por: Urwyler, Pascal, et al.
Publicado: (2020)

Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks
por: Bernstein, Jonathan A., et al.
Publicado: (2020)

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
por: Riedl, Marc A., et al.
Publicado: (2020)

Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema
por: Bernstein, Jonathan A, et al.
Publicado: (2012)

Management of acute attacks of hereditary angioedema: role of ecallantide
por: Duffey, Hannah, et al.
Publicado: (2015)

Food as a trigger for abdominal angioedema attacks in patients with hereditary angioedema
por: Steiner, Urs C., et al.
Publicado: (2018)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus
por: Grivcheva-Panovska, Vesna, et al.
Publicado: (2020)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

Management of acute attacks of hereditary angioedema: potential role of icatibant
por: Longhurst, Hilary J
Publicado: (2010)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency
por: Rubinstein, Eitan, et al.
Publicado: (2014)

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
por: Tyson, Christopher, et al.
Publicado: (2019)

Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
por: Lumry, William, et al.
Publicado: (2020)

Prevention of Recurrent Attacks of Hereditary Angioedema (HAE): Berotralstat and Its Oral Bioavailability
por: Diaz-Menindez, Maximiliano, et al.
Publicado: (2023)

New treatments addressing the pathophysiology of hereditary angioedema
por: Davis, Alvin E
Publicado: (2008)

Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema
por: Satomura, Atsushi, et al.
Publicado: (2017)

Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
por: Maurer, Marcus, et al.
Publicado: (2013)

Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014)

Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema
por: Mathis, Amanda, et al.
Publicado: (2022)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
por: Floccard, Bernard, et al.
Publicado: (2012)

Recombinant follitropin alfa/lutropin alfa in fertility treatment
por: Gibreel, Ahmed, et al.
Publicado: (2010)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

The Interplay of COVID-19 and Hereditary Angioedema: Preventing an Acute Attack
por: Park, Erin G, et al.
Publicado: (2022)

Angioedema in the emergency department: a practical guide to differential diagnosis and management
por: Bernstein, Jonathan A., et al.
Publicado: (2017)

Determining biomarkers for evaluation and diagnosis of hereditary angioedema
por: Singh, Umesh, et al.
Publicado: (2022)

Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
por: Cohn, Danny M., et al.
Publicado: (2023)

Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor
por: Cardona, Lourdes Pastó, et al.
Publicado: (2010)

Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks
por: Bernstein, Jonathan A., et al.
Publicado: (2019)

Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
por: Reshef, Avner, et al.
Publicado: (2019)

Clinical Characteristics and Management of Angioedema Attacks in Polish Adult Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Piotrowicz-Wójcik, Katarzyna, et al.
Publicado: (2021)

Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema
por: Ohsawa, Isao, et al.
Publicado: (2013)

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema
por: Farkas, Henriette, et al.
Publicado: (2021)

A novel murine in vivo model for acute hereditary angioedema attacks
por: Bupp, Sujata, et al.
Publicado: (2021)

Prodromes predict attacks of hereditary angioedema: Results of a prospective study
por: Leibovich‐Nassi, Iris, et al.
Publicado: (2022)

Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk
por: Reshef, A, et al.
Publicado: (2015)

Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain
por: Staller, Kyle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qpvo31lldsf1p1lktjsh0nueh3